Fortress Biotech
FBIO
#9380
Rank
HK$0.68 B
Marketcap
HK$22.02
Share price
2.91%
Change (1 day)
25.80%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2025 (TTM): -HK$0.7 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are HK$59.3 Million. In 2024 the company made an earning of -HK$0.94 Billion, an increase over its 2023 earnings that were of -HK$1.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.7 Billion-26.14%
2024 -HK$0.94 Billion-21.6%
2023 -HK$1.2 Billion-28.03%
2022 -HK$1.67 Billion29.88%
2021 -HK$1.28 Billion59.8%
2020 -HK$0.81 Billion1.17%
2019 -HK$0.8 Billion-19.84%
2018 -HK$0.99 Billion28.99%
2017 -HK$0.77 Billion37.92%
2016 -HK$0.56 Billion32.31%
2015 -HK$0.42 Billion164.31%
2014 -HK$0.16 Billion-45.14%
2013 -HK$0.29 Billion37.55%
2012 -HK$0.22 Billion-22.91%
2011 -HK$0.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-HK$0.27 Billion-61.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
HK$0.19 B-127.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-HK$0.92 Billion 32.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-HK$0.27 Billion-61.90%๐Ÿ‡บ๐Ÿ‡ธ USA